Cargando…
Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis
BACKGROUND: Multiple myeloma (MM) is an incurable plasma cell malignancy. Red cell distribution width (RDW) is a prognostic marker in various diseases, solid tumors, and hematologic neoplasms, but its prognostic significance in MM is controversial. In this study, we aimed to assess the relationship...
Autores principales: | Chen, Xiaomin, Liu, Jiayue, Duan, Jialin, Xiong, Hao, Liu, Yang, Zhang, Xinwen, Huang, Chunlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297629/ https://www.ncbi.nlm.nih.gov/pubmed/35854269 http://dx.doi.org/10.1186/s12885-022-09902-9 |
Ejemplares similares
-
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
por: Zhang, Xinwen, et al.
Publicado: (2021) -
The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
por: Mielnik, Michał, et al.
Publicado: (2023) -
Prognostic value of RDW in cancers: a systematic review and meta-analysis
por: Hu, Linhui, et al.
Publicado: (2016) -
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017) -
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019)